Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 30-39 , September 2006

Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis

  • Stefanie J. Kirwin

      Affiliations

    • Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • ,
  • Kenichi C. Dowdell

      Affiliations

    • Department of Neurology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Present address: NIAID, Laboratory of Clinical Infectious Diseases, Bethesda, MD 20892, USA.
    • ,
  • Claudia Hindinger

      Affiliations

    • Department of Neurology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Present address: Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA.
    • ,
  • Ni Feng

      Affiliations

    • Department of Neurology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • ,
  • Cornelia C. Bergmann

      Affiliations

    • Department of Neurology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Department of Pathology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Present address: Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA.
    • ,
  • David R. Hinton

      Affiliations

    • Department of Pathology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • ,
  • Stephen A. Stohlman

      Affiliations

    • Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Department of Neurology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Department of Pathology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA
    • Corresponding Author InformationCorresponding author. Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, 1333 San Pablo Ave, Los Angeles, CA 90033, USA. Tel.: +1 216 445 9796; fax: +1 216 444 7927.

Received 29 March 2006 ,Revised 8 May 2006 ,Accepted 18 May 2006.

References 

  1. Barrat FJ, et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002;195:603–616
  2. Bebo BF, et al. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J. Neurosci. Res. 1998;52:420–426
  3. Begolka WS, et al. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 1998;161:4437–4446
  4. Bergmann CC, et al. Perforin-mediated effector function within the central nervous system requires IFN-γ-mediated MHC up-regulation. J. Immunol. 2003;170:3204–3213
  5. Bettelli E, et al. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 1998;161:3299–3306
  6. Bongioanni MR, et al. Systemic high-dose recombinant-α-2a-interferon therapy modulates lymphokine production in multiple sclerosis. J. Neurol. Sci. 1996;143:91–99
  7. Brown AM, McFarlin DE. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 1981;45:278–284
  8. Cannella B, et al. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996;45:735–746
  9. Chitnis T, et al. Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. J. Immunol. 2004;172:4260–4265
  10. Coffman RL, et al. The stability and reversibility of Th1 and Th2 populations. Curr. Top. Microbiol. Immunol. 1999;238:1–12
  11. Corbin GA, Harty JT. T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen. J. Immunol. 2005;174:718–726
  12. Croxford JL, et al. Different therapeutic outcomes in experimental allergic encephalomyelitis dependant upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system. J. Immunol. 2001;166:4124–4130
  13. Cua DJ, et al. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 1995;155:4052–4059
  14. Cua DJ, et al. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function. J. Immunol. 1996;157:2830–2836
  15. Cua DJ, et al. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 1999;189:1005–1010
  16. Cua DJ, et al. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 2001;166:602–608
  17. Dhib-Jalbut S. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Pharmacol. Ther. 2003;98:245–255
  18. Duda PW, et al. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 2000;105:967–976
  19. Falcone M, Bloom BR. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 1997;185:901–907
  20. Falcone M, et al. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J. Immunol. 1998;160:4822–4830
  21. Fillatreau S, et al. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002;3:944–950
  22. Greter M, et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 2005;11:328–334
  23. Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J. Autoimmun. 2003;20:281–285
  24. Harling-Berg CJ, et al. Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation. J. Neuroimmunol. 1999;101:111–127
  25. Hickey W. Basic principles of immunological surveillance of the normal central nervous system. Glia. 2001;36:118–124
  26. IFNB Multiple Sclerosis Study Group and University of British Columbia MS/MRI Analysis Group. Interferon β-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology. 1995;45:1277–1285
  27. Kennedy M, et al. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 1992;149:2496–2505
  28. Khoruts A, et al. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol. 1995;155:5011–5017
  29. Kim C, Tse HY. Adoptive transfer of murine experimental autoimmune encephalomyelitis in SJL. Thy-1 congenic mouse strains. J. Neuroimmunol. 1993;46:129–136
  30. Liblau RS, et al. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 1995;16:34–38
  31. Matejuk A, et al. Opposing roles for TGF-β1 and TGF-β3 isoforms in experimental autoimmune encephalomyelitis. Cytokine. 2004;25:45–51
  32. Mathisen PM, et al. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 1997;186:159–164
  33. Matsushima GK, Stohlman SA. Maturation of the delayed-type hypersensitivity response in SJL mice: absence of effector cell induction. Eur. J. Immunol. 1988;18:1411–1416
  34. McGeachy MJ, et al. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+ CD25+ regulatory cells within the central nervous system. J. Immunol. 2005;175:3025–3032
  35. McMahon EJ, et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005;11:335–339
  36. Mirowska D, et al. Changes of percentages in immune cells phenotypes and cytokines production during two-year IFN-β-1a treatment in multiple sclerosis patients. J. Neurol. 2003;250:1229–1236
  37. Moore KW, et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001;19:683–765
  38. Nagelkerken L, et al. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. Int. Immunol. 1997;9:1243–1251
  39. Neuhaus O, et al. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. PNAS. 2000;97:7452–7457
  40. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J. Immunol. 1981;127:1420–1423
  41. Ramírez F, Mason D. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Eur. J. Immunol. 2000;30:747–758
  42. Rott O, et al. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994;24:1434–1440
  43. Rudick RA, et al. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 1996;40:618–627
  44. Sakaguchi S, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995;155:1151–1164
  45. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988;23:339–346
  46. Shaw MK, et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 1997;185:1711–1714
  47. Stohlman SA, et al. The defect in delayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur. J. Immunol. 1985;15:913–916
  48. Stohlman SA, et al. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. J. Immunol. 1999;163:6338–6344
  49. Targoni OS, et al. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 2001;166:4757–4764
  50. van der Veen RC, Stohlman SA. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 1993;48:213–220
  51. Voskuhl RR, et al. Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis. Ann. Neurol. 1996;39:724–733
  52. Wållberg M, et al. Vaccination with myelin oligodendrocyte glycoprotein adsorbed to alum effectively protects DBA/1 mice from experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2003;33:1539–1547
  53. Wildbaum G, et al. Plasmid DNA encoding IFN-γ-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 2002;168:5885–5892
  54. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990;8:579–621

PII: S0165-5728(06)00201-3

doi: 10.1016/j.jneuroim.2006.05.015

Journal of Neuroimmunology
Volume 178, Issue 1 , Pages 30-39 , September 2006

Article Tools

* Image Usage & Resolution